2-阿米诺佐提亚:为氨酸激酶向性抗癌剂的特权支架
Rani D Navle1, Nirmala V Shinde1, Arti S Raut1
1Department of Pharmaceutical Chemistry, SMBT College of Pharmacy, Nashik, India.
概括
2-阿米诺索衍生物显示出作为抗癌剂的前景,向CDK和EGFR等酶,以及非酶标,如BCL-2. 药物化学研究重点是优化替代品,以提高针对性癌症治疗的疗效和特异性.
科学领域:
- 药用化学 医学化学
- 药物发现 药物发现 药物发现
- 在瘤学瘤学.
背景情况:
- 2-Aminobenzothiazole是一种异环基架,由于其平面结构和结合瘤点的能力,具有已被证明的抗癌潜力.
- 最近的药物化学努力 (2015-2024) 专注于设计替代的2-aminobenzothiazoles,以改善抗癌活性和点特异性.
研究的目的:
- 从2015年到2024年,批判性地评估基于2-aminobenzothiazole的抗癌剂的研究和开发.
- 分析它们的抗癌点,结构-活性关系 (SAR) 和作用机制.
- 为未来的癌症治疗突出针对激酶和非激酶通路的化合物.
主要方法:
- 科学文献和专利的审查,重点是2-aminobenzothiazole衍生物.
- 对C-2,C-5,C-6和C-7位置的替代物结构-活性关系 (SAR) 的分析.
- 系统评估已识别的抗癌点和作用机制.
主要成果:
- 确定了关键激酶标,包括CDKs,奥罗拉激酶,RAF激酶和受体/非受体氨酸激酶 (例如EGFR,VEGFR-2,MET).
- 突出非酶标如BCL-2家族,HDACs,表观遗传修饰剂,HSP90,p53和拓酶等.
- 强调了商业上可用的药物,专利化合物和具有2-aminobenzothiazole核心的转化候选物的存在.
结论:
- 2-Aminobenzothiazole衍生物具有双重的机械向性,对酶和其他关键癌症途径都起作用.
- 在佐醇环上的优化替代物产生了强效和特定的抗癌剂.
- 这些化合物代表了有价值的结构,用于开发创新的,向的抗癌疗法.
相关概念视频
Receptor Tyrosine Kinases
18.8K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
18.8K
Protein Kinases and Phosphatases
15.2K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.2K
Protein Kinases and Phosphatases
4.5K
4.5K
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
550
Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
550
Subviral Agents
574
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
574
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H
6.7K
All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.7K


